Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04468633 · ClinicalTrials.gov registry record · NA
The Baerveldt Versus ClearPath Comparison Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT04468633 is a NA study that has completed, run by Duke University. The registered enrollment target is 76 participants.
The verdict
NCT04468633, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
This is a randomized prospective study of post-operative surgical outcomes and complication rates in patients with a Baerveldt 350 implant vs the Ahmed ClearPath implant. Each subject will be randomized to the Baerveldt group or ClearPath group at the time of consent for the study.
Interventions
- DEVICE Baerveldt 350 implant
- DEVICE Ahmed ClearPath 350 implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2020-12-17 |
| Est. Completion | 2023-06-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04468633
The ClinicalTrials.gov registry entry for NCT04468633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Baerveldt 350 implant is the first listed.
NCT04468633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04468633 about?
NCT04468633 is a clinical study titled "The Baerveldt Versus ClearPath Comparison Study". This is a randomized prospective study of post-operative surgical outcomes and complication rates in patients with a Baerveldt 350 implant vs the Ahmed ClearPath implant. Each subject will be randomized to the Baerveldt group or ClearPath group at the time of consent for the study.
What is the current status of trial NCT04468633?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2020-12-17. Estimated completion is 2023-06-29.
What interventions are being tested in trial NCT04468633?
The interventions under investigation include: Baerveldt 350 implant (DEVICE), Ahmed ClearPath 350 implant (DEVICE).
Who is sponsoring clinical trial NCT04468633?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.